z-logo
open-access-imgOpen Access
Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system
Author(s) -
Sheng Yang,
Chuan Qin,
Zi-Wei Hu,
Luo-Qi Zhou,
Hai-Han Yu,
Man Chen,
Dale B. Bosco,
Wei Wang,
LongJun Wu,
DaiShi Tian
Publication year - 2021
Publication title -
neurobiology of disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.205
H-Index - 166
eISSN - 1095-953X
pISSN - 0969-9961
DOI - 10.1016/j.nbd.2021.105290
Subject(s) - microglia , biology , inflammation , reprogramming , immune system , microbiology and biotechnology , metabolic pathway , central nervous system , oxidative phosphorylation , phenotype , neuroscience , glycolysis , metabolism , immunology , biochemistry , cell , gene
In response to various types of environmental and cellular stress, microglia rapidly activate and exhibit either pro- or anti-inflammatory phenotypes to maintain tissue homeostasis. Activation of microglia can result in changes in morphology, phagocytosis capacity, and secretion of cytokines. Furthermore, microglial activation also induces changes to cellular energy demand, which is dependent on the metabolism of various metabolic substrates including glucose, fatty acids, and amino acids. Accumulating evidence demonstrates metabolic reprogramming acts as a key driver of microglial immune response. For instance, microglia in pro-inflammatory states preferentially use glycolysis for energy production, whereas, cells in anti-inflammatory states are mainly powered by oxidative phosphorylation and fatty acid oxidation. In this review, we summarize recent findings regarding microglial metabolic pathways under physiological and pathological circumstances. We will then discuss how metabolic reprogramming can orchestrate microglial response to a variety of central nervous system pathologies. Finally, we highlight how manipulating metabolic pathways can reprogram microglia towards beneficial functions, and illustrate the therapeutic potential for inflammation-related neurological diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom